Gençöz Faruk, Gençöz Tülin, Soykan Attila
Department of Psychology, Middle East Technical University, Ankara, Turkey.
Psychol Health Med. 2007 Aug;12(4):450-9. doi: 10.1080/13548500600892054.
This study aimed to examine the reliability and validity of clinician-rated psychiatric scales for end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) treatment in Turkey. For this, the Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), Global Assessment of Functioning (GAF) Scale, Clinical Global Impression (CGI) Scale, and Mini Mental State Exam (MMSE) were administered to 45 ESRD outpatients undergoing HD treatment. Regarding the reliability of HDRS and HARS, internal consistency and split-half reliability analyses revealed acceptable coefficients. The test - retest reliability coefficients were also examined for all measures after a period of a month, and despite this relatively long time interval, test - retest reliability coefficients were above .60 for all measures. Concerning the validity studies, all these scales revealed suitable convergent, discriminant, and criterion validity outcomes. A cut-off point of 10 for HDRS is suggested for the identification of depression in this population. In general, the findings of this study indicate that HDRS, HARS, CGI, GAF, and MMSE are reliable and valid instruments that can be used among ESRD patients undergoing HD.
本研究旨在检验土耳其接受血液透析(HD)治疗的终末期肾病(ESRD)患者中,临床医生评定的精神科量表的信度和效度。为此,对45名接受HD治疗的ESRD门诊患者施测了汉密尔顿抑郁评定量表(HDRS)、汉密尔顿焦虑评定量表(HARS)、功能总体评定量表(GAF)、临床总体印象量表(CGI)和简易精神状态检查表(MMSE)。关于HDRS和HARS的信度,内部一致性和分半信度分析显示系数可接受。一个月后还对所有测量指标的重测信度系数进行了检验,尽管时间间隔相对较长,但所有测量指标的重测信度系数均高于0.60。关于效度研究,所有这些量表均显示出合适的聚合效度、区分效度和效标效度结果。建议将HDRS的临界值设定为10,以识别该人群中的抑郁症。总体而言,本研究结果表明,HDRS、HARS、CGI、GAF和MMSE是可靠且有效的工具,可用于接受HD治疗的ESRD患者。